filings.toolsItem 5. Other Information
0K characters. Original on sec.gov ·
Item 5. Other Information
During the quarter ended July 1, 2023, none of our officers or directors adopted or terminated any contract, instruction, or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or any “non-Rule 10b5-1 trading arrangement” as defined in Item 408(c)of Regulation S-K.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Previous: Item 1A. Risk Factors · Next: Item 6. Exhibits
Sponsor Sponsor this sector. One slot per industry, shown on every filing in it. Details